Modern Management of Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) is a multi-part educational video series to support hematologists/oncologists and multidisciplinary care teams in making evidence-based, patient-centered decisions for the management of BPDCN. The series emphasizes early recognition and diagnosis, safe delivery of therapy, proactive management of treatment-related toxicities such as capillary leak syndrome, and coordination of care across academic and community settings.
Thomas W. LeBlanc, MD, MA, MHS, FAAHPM, FASCO, Associate Professor of Medicine at Duke University School of Medicine and Chief Patient Experience and Safety Officer at Duke Cancer Institute, and Taylor Kujawa, PharmD, Hematology Clinical Pharmacist at Huntsman Cancer Institute at University of Utah, discuss their own experiences treating BPDCN as well as emerging data shaping the field. Across three videos, gain insights and learn best practices for managing this disease and improving patient outcomes.
Learning Objectives
Thomas W. LeBlanc, MD, MA, MHS, FAAHPM, FASCOAssociate Professor of MedicineDuke University School of Medicine Chief Patient Experience and Safety OfficerDuke Cancer InstituteDurham, NC
Taylor Kujawa, PharmDHematology Clinical PharmacistHuntsman Cancer Institute at University of Utah Salt Lake City, UT